Cerebral Palsy (CP) Completed Phase 3 Trials for Botulinum toxin type A (DB00083)

Also known as: CP (Cerebral Palsy) / Cerebral Palsy / Palsy cerebral / Cerebral palsy (&/or infantile) &/or infantile hemiplegia / Cerebral palsy [Ambiguous] / Infantile spastic cerebral palsy (disorder) / Cerebral palsy (disorder)

IndicationStatusPhase
DBCOND0044923 (Cerebral Palsy (CP))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03469999Effect of Dysport Injections on Energy Expenditure and Walking Efficiency in Children With Cerebral PalsyTreatment
NCT02270736Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual DisabilityTreatment
NCT02002884Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral PalsyTreatment
NCT01251380Dysport® Pediatric Lower Limb Spasticity Follow-on StudyTreatment
NCT01249417Dysport® Pediatric Lower Limb Spasticity StudyTreatment
NCT03472261Integrated Management of Pronation Deformity in Cerebral PalsyTreatment
NCT01437644The Post-Operative Pain in Cerebral Palsy (POPPIES) TrialTreatment
NCT01603615BOTOX® Open-Label Treatment in Pediatric Upper Limb SpasticityTreatment
NCT01603602BOTOX® Treatment in Pediatric Upper Limb SpasticityTreatment
NCT01603641BOTOX® Open-Label Treatment in Pediatric Lower Limb SpasticityTreatment
NCT01603628BOTOX® Treatment in Pediatric Lower Limb SpasticityTreatment
NCT03302871Integrated Management Enhances Functional Gains in Children With Cerebral Palsy Treated by BoNT-ATreatment
NCT03306212Efficacy of Intermittent Serial Casting on Spastic Wrist Flexion DeformityTreatment